Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 6 de 6
1.
Curr Mol Med ; 2023 Jun 02.
Article En | MEDLINE | ID: mdl-37278035

Resveratrol (Res), a polyphenol found in red wine, has been shown to decelerate aging, the progressive loss of physiological integrity and cellular senescence, characterized by the inability to progress through the cell cycle. No successful clinical trials have yet to be completed in humans on dose limitations. Yet, the potent anti-aging and anti-senescence efficacy of Res has been documented in several in vivo animal models. In this review, we highlight the molecular mechanisms of Res efficacy in anti-aging disorders, such as diabetes, neurodegenerative disorders, eye diseases, and cardiovascular diseases.

2.
Biomed Pharmacother ; 145: 112179, 2022 Jan.
Article En | MEDLINE | ID: mdl-34736076

Astaxanthin (AST) is a red pigmented carotenoid with significant antioxidant, anti-inflammatory, anti-proliferative, and anti-apoptotic properties. In this study, we summarize the available literature on the anti-inflammatory efficacy of AST in various chronic and acute disorders, such as neurodegenerative, renal-, hepato-, skin- and eye-related diseases, as well as gastrointestinal disorders. In addition, we elaborated on therapeutic efficacy of AST and the role of several pathways, including PI3K/AKT, Nrf2, NF-κB, ERK1/2, JNK, p38 MAPK, and JAK-2/STAT-3 in mediating its effects. However, additional experimental and clinical studies should be performed to corroborate the anti-inflammatory effects and protective effects of AST against inflammatory diseases in humans. Nevertheless, this review suggests that AST with its demonstrated anti-inflammatory property may be a suitable candidate for drug design with novel technology.


Anti-Inflammatory Agents/pharmacology , Inflammation/drug therapy , Animals , Antioxidants/pharmacology , Humans , Inflammation/physiopathology , Xanthophylls/pharmacology
3.
Cancer Cell Int ; 21(1): 468, 2021 Sep 06.
Article En | MEDLINE | ID: mdl-34488773

Signal transducer and activator of transcription 3 (STAT3) induces breast cancer malignancy. Recent clinical and preclinical studies have demonstrated an association between overexpressed and activated STAT3 and breast cancer progression, proliferation, metastasis, and chemoresistance. Resveratrol (RES), a naturally occurring phytoalexin, has demonstrated anti-cancer activity in several disease models. Furthermore, RES has also been shown to regulate the STAT3 signaling cascade via its anti-oxidant and anti-inflammatory effects. In the present review, we describe the STAT3 cascade signaling pathway and address the therapeutic targeting of STAT3 by RES as a tool to mitigate breast cancer.

4.
Biomed Pharmacother ; 140: 111782, 2021 Aug.
Article En | MEDLINE | ID: mdl-34087693

Gastrointestinal cancer is one of the most common cancers globally. Melatonin, a natural endogenous body hormone, has been of interest for years, due to its anti-cancer characteristics, such as antiproliferative, antimetastatic, and cytotoxic as well as apoptotic induction. Through regulating several proteins such as melatonin upregulated mRNAs and proteins of downregulated Bcl-2-associated X protein (Bax), and B-cell lymphoma 2 (Bcl-2), as well as cytoplasmic protein such as calcium-binding proteins calmodulin or tubulin, and nuclear receptors, including RORα/RZR, and acts by non-receptor-regulated mechanisms, melatonin can exert anti-cancer efficacy. Moreover, melatonin modulates angiogenesis by targeting mRNA and protein expression of endothelin-converting enzyme (ECE-1) protein. In the present review, we address in vivo, in vitro and clinical reports on its anti-cancer efficacies, and the molecular mechanisms of action responsible for these effects. We advance the possibility of therapeutic melatonin administration for cancer therapy.


Gastrointestinal Neoplasms/drug therapy , Melatonin/therapeutic use , Animals , Apoptosis/drug effects , Cell Proliferation/drug effects , Gastrointestinal Neoplasms/immunology , Gastrointestinal Neoplasms/metabolism , Gastrointestinal Neoplasms/pathology , Humans , Melatonin/pharmacology , Receptors, Melatonin/metabolism
5.
Biomed Pharmacother ; 137: 111374, 2021 May.
Article En | MEDLINE | ID: mdl-33761600

Astaxanthin (ATX) is a red pigment carotenoid present in shrimp, salmon, crab, and asteroidean. Several studies have corroborated the anti-oxidant efficacy of ATX. In addition, ATX has anti-inflammatory, anti-apoptotic and anti-proliferative properties. In the present review, we discuss the role of Nrf2 in mediating the anti-cancer, anti-aging, neuroprotective, lung-protective, skin-protective, cardioprotective, hepatoprotective, anti-diabetic and muscloprotective effects of ATX.


Antioxidants/pharmacology , Antioxidants/therapeutic use , NF-E2-Related Factor 2/drug effects , Animals , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Humans , Oxidative Stress/drug effects , Protective Agents/pharmacology , Protective Agents/therapeutic use , Xanthophylls/pharmacology , Xanthophylls/therapeutic use
6.
Biomed Pharmacother ; 138: 111492, 2021 Jun.
Article En | MEDLINE | ID: mdl-33743334

Thymoquinone (TQ, 2-methyl-5-isopropyl-1, 4-benzoquinone), a monoterpene molecule present in Nigella sativa L., has an anti-inflammatory, anti-oxidant, and anti-apoptotic properties in several disorders such as asthma, hypertension, diabetes, inflammation, bronchitis, headache, eczema, fever, dizziness and influenza. TQ exerts its anti-inflammatory and anti-oxidant effects via several molecular pathways, including the release of cytokines, and activation of cyclooxygenase-2 (COX2), nuclear factor erythroid 2-related factor 2 (Nrf2), phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT), nuclear factor kappa-light-chain-enhancer of activated B (NF-Κß). In this review, recent reports on the anti-inflammatory efficacy of TQ in heart disorders, respiratory diseases, neuroinflammation, diabetes and arthritis are summarized. We suggest that further investigation is necessary to better characterize the efficacy of TQ as a therapeutic agent.


Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Benzoquinones/pharmacology , Benzoquinones/therapeutic use , Cytoprotection/drug effects , Inflammation Mediators/antagonists & inhibitors , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Cardiovascular Diseases/metabolism , Cardiovascular Diseases/prevention & control , Cytoprotection/physiology , Humans , Inflammation Mediators/metabolism , Metabolic Diseases/metabolism , Metabolic Diseases/prevention & control
...